- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
极度弱势行情中，投资者可暂时观望。
- 中期趋势：
有加速上涨趋势。
- 长期趋势：
已有158家主力机构披露2025-06-30报告期持股数据，持仓量总计2.83亿股，占流通A股50.84%
- 波段诊断：
-
技术面诊股
诊断结果：5.2技术面打败了35%的股票
技术面评分前10的股票
近期的平均成本为20.84元。多头行情中，并且有加速上涨趋势。
平均成本
近期的平均成本为20.84元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"20.84","date":1761727014,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑输大盘，跑输行业平均水平。
[{"date":"2025.10.30","stock":"-1.19","trade":"-1.13","ind":"-0.73"},{"date":"2025.10.29","stock":"0.14","trade":"-0.32","ind":"0.70"},{"date":"2025.10.28","stock":"-0.76","trade":"-0.54","ind":"-0.22"},{"date":"2025.10.27","stock":"-3.21","trade":"-0.12","ind":"1.18"},{"date":"2025.10.24","stock":"-0.14","trade":"-0.63","ind":"0.71"},{"date":"2025.10.23","stock":"-0.50","trade":"-0.36","ind":"0.22"},{"date":"2025.10.22","stock":"0.37","trade":"0.70","ind":"-0.07"},{"date":"2025.10.21","stock":"1.34","trade":"0.86","ind":"1.36"},{"date":"2025.10.20","stock":"-0.28","trade":"0.20","ind":"0.63"},{"date":"2025.10.17","stock":"-2.61","trade":"-0.94","ind":"-1.95"},{"date":"2025.10.16","stock":"-0.27","trade":"0.75","ind":"0.10"},{"date":"2025.10.15","stock":"-0.31","trade":"1.37","ind":"1.22"},{"date":"2025.10.14","stock":"1.27","trade":"0.32","ind":"-0.62"},{"date":"2025.10.13","stock":"0.05","trade":"-0.86","ind":"-0.19"},{"date":"2025.10.10","stock":"0.78","trade":"1.31","ind":"-0.94"},{"date":"2025.10.09","stock":"0.18","trade":"0.26","ind":"1.32"},{"date":"2025.09.30","stock":"-0.05","trade":"0.12","ind":"0.52"},{"date":"2025.09.29","stock":"-0.41","trade":"0.13","ind":"0.90"},{"date":"2025.09.26","stock":"0.83","trade":"-0.51","ind":"-0.65"},{"date":"2025.09.25","stock":"0.23","trade":"-0.70","ind":"-0.01"},{"date":"2025.09.24","stock":"3.97","trade":"1.12","ind":"0.83"}]
太极集团,上证指数,中药指数
压力支撑
该股压力位为20.86元，支撑位为20.70元。
[{"text":"\u538b\u529b\u4f4d","value":"20.86","date":1761753600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"20.70","date":1761753600,"color":"0x0b52a1"}]
多空趋势
多头行情中，并且有加速上涨趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：1.4资金面打败了1%的股票
主力控盘前10的股票
行业资金
中药行业， 近5日资金流出较多，不建议投资者关注该行业的个股。
更新时间：10月30日 20:30
| 机构今日流向(万元) | -1685.64 | 机构5日流向(万元) | -7715.65 |
| 机构10日流向(万元) | -10038.31 | 机构20日流向(万元) | -11575.46 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量减少1492.01万股，其中基金净减仓23家，主力净减仓94家，请投资者中长期谨慎为宜。
截止2025-06-30，共158家主力机构（基金151家，一般法人5家，保险公司1家，信托公司1家），持仓量总计28314.77万股，占流通A股50.84%
其中，基金持仓与2024-12-31相比：
增仓：17家 ，增持 85.56万股
减仓：40家 ，减持 1444.97万股
新出现在主力名单中：86家 ，持有4554.81万股
从主力名单中消失：180家 ，原持有4751.29万股
其中，基金持仓与2024-12-31相比：
增仓：17家 ，增持 85.56万股
减仓：40家 ，减持 1444.97万股
新出现在主力名单中：86家 ，持有4554.81万股
从主力名单中消失：180家 ，原持有4751.29万股
消息面诊股
诊断结果：5.4消息面打败了53%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 太极集团：前三季度营收超80亿元，ESG战略构筑长
2025-10-30 - 太极集团入选央视中国企业ESG行动报告，三季报现金
2025-10-30 - 太极集团：10月29日获融资买入1285.63万元
2025-10-30 - 太极集团：公司坚定不移深化改革以“科技创新”与“营
2025-10-29 - 太极集团：公司完成回购使用资金总额1.2亿元
2025-10-29 - 太极集团：公司用于流感的预防及治疗的中药主要有羚羊
2025-10-29 - 太极集团：将协同国药集团积极推进解决同业竞争
2025-10-29 - 国药太极在全国医药行业QC成果发表中获奖数再创新高
2025-10-29 - 太极集团前3季净利降7成去年降97% 换帅后业绩连
2025-10-29 - 太极集团：10月28日获融资买入2276.71万元
2025-10-29
消息列表
| 一般消息 | 股东大会 | 临时股东大会 | 2025-10-25 |
| 一般消息 | 募资投向 | 公司购买资产 | 2025-10-25 |
| 一般消息 | 重大事项 | 关联交易 | 2025-10-25 |
| 一般消息 | 高管变动 | 因工作调整原因 | 2025-10-22 |
| 一般消息 | 募资投向 | 公司出售资产 | 2025-09-30 |
| 一般消息 | 高管变动 | 退休 | 2025-09-02 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-22 |
| 一般消息 | 募资投向 | 公司购买资产 | 2025-08-22 |
| 一般消息 | 募资投向 | 公司出售资产 | 2025-08-15 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-08-06 |
| 一般消息 | 募资投向 | 2025-07-19 | |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-07-19 |
| 重大利空 | 业绩预告 | 业绩大幅下降 | 2025-07-15 |
| 一般消息 | 募资投向 | 公司购买资产 | 2025-07-09 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-06-12 |
| 一般消息 | 高管变动 | 因达法定退休年龄 | 2025-06-09 |
| 一般消息 | 高管变动 | 工作变动 | 2025-06-04 |
| 一般消息 | 高管变动 | 因工作原因 | 2025-05-27 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-05-07 |
| 一般消息 | 募资投向 | 公司购买资产 | 2025-04-25 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-04-04 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-03-29 |
| 一般消息 | 募资投向 | 公司购买资产 | 2025-03-29 |
| 一般消息 | 重大事项 | 关联交易 | 2025-03-29 |
| 重大利空 | 业绩预告 | 业绩大幅下降 | 2025-03-27 |
| 一般消息 | 高管变动 | 委员会调整 | 2025-03-26 |
| 一般消息 | 重大事项 | 关联交易 | 2025-03-21 |
| 一般消息 | 募资投向 | 公司购买资产 | 2025-03-04 |
| 一般消息 | 高管变动 | 因工作调整 | 2025-03-03 |
| 一般消息 | 资产重组 | 公司股权转让 | 2025-02-28 |
| 重大利空 | 业绩预告 | 业绩大幅下降 | 2025-01-24 |
| 一般消息 | 高管变动 | 因达法定退休年龄 | 2025-01-03 |
| 一般消息 | 重大事项 | 关联交易 | 2024-12-18 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 0条 | 0条 | 0条 |
| 利空 | 3条 | 3条 | 0条 |
行业面诊股
诊断结果：5.4行业面打败了66%的股票
中药行业最新资金流向
近10日来该行业走势不明显，明显跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，明显跑输大盘。
[{"date":"2025.10.30","price":"-0.73","value":"-1.13"},{"date":"2025.10.29","price":"0.70","value":"-0.32"},{"date":"2025.10.28","price":"-0.22","value":"-0.54"},{"date":"2025.10.27","price":"1.18","value":"-0.12"},{"date":"2025.10.24","price":"0.71","value":"-0.63"},{"date":"2025.10.23","price":"0.22","value":"-0.36"},{"date":"2025.10.22","price":"-0.07","value":"0.70"},{"date":"2025.10.21","price":"1.36","value":"0.86"},{"date":"2025.10.20","price":"0.63","value":"0.20"},{"date":"2025.10.17","price":"-1.95","value":"-0.94"},{"date":"2025.10.16","price":"0.10","value":"0.75"},{"date":"2025.10.15","price":"1.22","value":"1.37"},{"date":"2025.10.14","price":"-0.62","value":"0.32"},{"date":"2025.10.13","price":"-0.19","value":"-0.86"},{"date":"2025.10.10","price":"-0.94","value":"1.31"},{"date":"2025.10.09","price":"1.32","value":"0.26"},{"date":"2025.09.30","price":"0.52","value":"0.12"},{"date":"2025.09.29","price":"0.90","value":"0.13"},{"date":"2025.09.26","price":"-0.65","value":"-0.51"},{"date":"2025.09.25","price":"-0.01","value":"-0.70"},{"date":"2025.09.24","price":"0.83","value":"1.12"}]
上证指数,中药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 万邦德 | 36.09% | 2.61% | 5.4分 |
| 2 | 特一药业 | 21.71% | -1.95% | 5.9分 |
| 3 | 吉林敖东 | 14.29% | 5.32% | 5.7分 |
| 4 | 以岭药业 | 11.03% | 1.45% | 6.0分 |
| 5 | 信邦制药 | 8.41% | -4.83% | 5.0分 |
| 6 | 金花股份 | 7.14% | -1.45% | 5.8分 |
| 8 | 粤万年青 | 4.10% | -3.84% | 4.9分 |
| 10 | 华润三九 | 3.24% | -2.22% | 5.4分 |
| 12 | 方盛制药 | 2.96% | -0.33% | 5.4分 |
| 14 | 精华制药 | 2.35% | -2.37% | 5.3分 |
| 16 | ST葫芦娃 | 1.69% | -0.66% | 5.2分 |
| 18 | 嘉应制药 | 1.61% | -2.47% | 5.1分 |
| 20 | 千金药业 | 1.15% | -1.58% | 5.7分 |
| 22 | 陇神戎发 | 1.02% | -4.46% | 4.8分 |
| 24 | 红日药业 | 0.54% | -2.87% | 5.1分 |
| 26 | 九芝堂 | 0.40% | 0.61% | 5.4分 |
| 28 | 羚锐制药 | 0.27% | -3.00% | 5.4分 |
| 30 | 桂林三金 | 0.20% | -3.41% | 5.6分 |
| 32 | 盘龙药业 | -0.03% | -4.73% | 5.1分 |
| 34 | 维康药业 | -0.22% | -0.17% | 4.8分 |
| 36 | 康美药业 | -0.49% | -0.49% | 5.0分 |
| 38 | 广誉远 | -0.68% | -1.76% | 5.2分 |
| 40 | 众生药业 | -1.01% | -4.72% | 5.5分 |
| 42 | 同仁堂 | -1.54% | -0.38% | 4.8分 |
| 44 | 康惠股份 | -1.88% | -2.14% | 5.1分 |
| 46 | 云南白药 | -2.10% | -0.16% | 5.4分 |
| 48 | 东阿阿胶 | -2.33% | -3.05% | 4.6分 |
| 50 | 华森制药 | -3.09% | -5.15% | 4.7分 |
| 52 | 健民集团 | -3.26% | -0.58% | 5.3分 |
| 54 | 寿仙谷 | -3.48% | -2.92% | 5.0分 |
| 56 | 康缘药业 | -3.85% | -3.46% | 4.8分 |
| 58 | 太极集团 | -4.55% | -5.08% | 4.7分 |
| 60 | 太龙药业 | -5.15% | -5.01% | 4.8分 |
| 62 | 振东制药 | -6.23% | -9.56% | 4.4分 |
| 64 | 葵花药业 | -6.37% | -6.79% | 4.2分 |
| 66 | 贵州三力 | -7.92% | -4.74% | 4.8分 |
| 68 | 恩威医药 | -10.55% | -3.87% | 5.1分 |
| 70 | ST香雪 | -14.85% | -3.94% | 3.6分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 22/110 ， 36/110。
[{"date":"2025-09-30","value":"4.72","vol":"5.38"},{"date":"2025-06-30","value":"3.90","vol":"3.94"},{"date":"2025-03-31","value":"2.11","vol":"2.20"},{"date":"2024-12-31","value":"0.75","vol":"4.81"},{"date":"2024-09-30","value":"14.30","vol":"2.92"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
4.72 | 3.90 | 2.11 | 0.75 | 14.30 |
| 行业(%) | 5.38 | 3.94 | 2.20 | 4.81 | 2.92 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"28.56","vol":"53.52"},{"date":"2025-06-30","value":"27.70","vol":"52.43"},{"date":"2025-03-31","value":"28.86","vol":"52.92"},{"date":"2024-12-31","value":"39.32","vol":"52.40"},{"date":"2024-09-30","value":"42.30","vol":"52.75"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
28.56 | 27.70 | 28.86 | 39.32 | 42.30 |
| 行业(%) | 53.52 | 52.43 | 52.92 | 52.40 | 52.75 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 33/110 ， 38/110。
[{"date":"2025-09-30","value":"-22.49","vol":"-5.29"},{"date":"2025-06-30","value":"-27.63","vol":"-6.98"},{"date":"2025-03-31","value":"-32.79","vol":"-6.63"},{"date":"2024-12-31","value":"-20.72","vol":"-6.97"},{"date":"2024-09-30","value":"-14.36","vol":"-4.57"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-22.49 | -27.63 | -32.79 | -20.72 | -14.36 |
| 行业(%) | -5.29 | -6.98 | -6.63 | -6.97 | -4.57 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"-69.56","vol":"39.11"},{"date":"2025-06-30","value":"-71.94","vol":"2.33"},{"date":"2025-03-31","value":"-69.80","vol":"-36.42"},{"date":"2024-12-31","value":"-96.76","vol":"-142.71"},{"date":"2024-09-30","value":"-28.10","vol":"63.06"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-69.56 | -71.94 | -69.80 | -96.76 | -28.10 |
| 行业(%) | 39.11 | 2.33 | -36.42 | -142.71 | 63.06 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 4/110 ， 6/110。
[{"date":"2025-09-30","value":"0.57","vol":"0.36"},{"date":"2025-06-30","value":"0.40","vol":"0.24"},{"date":"2025-03-31","value":"0.20","vol":"0.12"},{"date":"2024-12-31","value":"0.87","vol":"0.49"},{"date":"2024-09-30","value":"0.73","vol":"0.37"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.57 | 0.40 | 0.20 | 0.87 | 0.73 |
| 行业(次) | 0.36 | 0.24 | 0.12 | 0.49 | 0.37 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"2.34","vol":"1.62"},{"date":"2025-06-30","value":"1.65","vol":"1.17"},{"date":"2025-03-31","value":"0.77","vol":"0.60"},{"date":"2024-12-31","value":"2.77","vol":"2.40"},{"date":"2024-09-30","value":"2.13","vol":"1.79"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
2.34 | 1.65 | 0.77 | 2.77 | 2.13 |
| 行业(次) | 1.62 | 1.17 | 0.60 | 2.40 | 1.79 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"2.12","vol":"8.38"},{"date":"2025-06-30","value":"9.88","vol":"20.17"},{"date":"2025-03-31","value":"-5.82","vol":"0.38"},{"date":"2024-12-31","value":"3.02","vol":"15.45"},{"date":"2024-09-30","value":"-12.73","vol":"6.15"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 2.12 | 9.88 | -5.82 | 3.02 | -12.73 |
| 行业 | 8.38 | 20.17 | 0.38 | 15.45 | 6.15 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"1.24","vol":"1.02"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"1.84","vol":"1.46"},{"date":"2024-09-30","value":"","vol":"0.00"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 1.24 | - | 1.84 | - |
| 行业 | 0.00 | 1.02 | 0.00 | 1.46 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 24/110 ， 19/110。
[{"date":"2025-09-30","value":"0.73","vol":"3.41"},{"date":"2025-06-30","value":"0.73","vol":"2.88"},{"date":"2025-03-31","value":"0.72","vol":"2.97"},{"date":"2024-12-31","value":"0.72","vol":"2.86"},{"date":"2024-09-30","value":"0.79","vol":"3.22"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
0.73 | 0.73 | 0.72 | 0.72 | 0.79 |
| 行业 | 3.41 | 2.88 | 2.97 | 2.86 | 3.22 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.45","vol":"2.43"},{"date":"2025-06-30","value":"0.45","vol":"2.11"},{"date":"2025-03-31","value":"0.41","vol":"2.20"},{"date":"2024-12-31","value":"0.38","vol":"2.09"},{"date":"2024-09-30","value":"0.43","vol":"2.40"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
0.45 | 0.45 | 0.41 | 0.38 | 0.43 |
| 行业 | 2.43 | 2.11 | 2.20 | 2.09 | 2.40 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 20/110 ， 3/110。
[{"date":"2025-09-30","value":"74.16","vol":"33.39"},{"date":"2025-06-30","value":"73.46","vol":"33.91"},{"date":"2025-03-31","value":"73.87","vol":"33.34"},{"date":"2024-12-31","value":"74.15","vol":"34.08"},{"date":"2024-09-30","value":"71.21","vol":"32.93"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
74.16 | 73.46 | 73.87 | 74.15 | 71.21 |
| 行业(%) | 33.39 | 33.91 | 33.34 | 34.08 | 32.93 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"2.98","vol":"0.82"},{"date":"2025-06-30","value":"2.88","vol":"0.74"},{"date":"2025-03-31","value":"2.94","vol":"0.72"},{"date":"2024-12-31","value":"2.99","vol":"0.74"},{"date":"2024-09-30","value":"2.55","vol":"3.16"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
2.98 | 2.88 | 2.94 | 2.99 | 2.55 |
| 行业(%) | 0.82 | 0.74 | 0.72 | 0.74 | 3.16 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以增持为主，认为该股票有一定投资价值。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 天风证券 | 2025-09-29 | 中性 | |
| 华创证券 | 2025-08-27 | 增持 | |
| 开源证券 | 2025-08-25 | 买入 | |
| 国金证券 | 2025-08-22 | 增持 |
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"-5.23","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"3.54","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"8.22","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"0.27","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"5.10","blueLineValue":"0.92","type":"YC"}]